Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human endotoxemia effects on bone marrow hematopoietic stem and progenitor cells
NL-OMON45383Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2018
- Countries
- 1
01
Overview
Open-label trial of lipopolysaccharide endotoxin (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Hematopoietic lineage differentiation of bone marrow cells and Functional capacity of hematopoietic stem and progenitor cells. Started Jan 2018; status: recruiting.
02
Drugs
lipopolysaccharide endotoxin
Beyond the preview
Go deeper on NL-OMON45383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45383.